Stable XIAP knockdown clones of HCT116 colon cancer cells are more sensitive to TRAIL, taxanes and irradiation in vitro
The DOI matches its Crossref record; 49 of the 49 references it cites were found in a registry or an index.
Abstract
Purpose To develop a model of X-linked inhibitor of apoptosis (XIAP) down regulation in colorectal cancer cell lines. This may be used to determine whether combination strategies have clinical potential.Methods A series of clones were developed using short hairpin RNA (shRNA) against XIAP stably expressed in HCT116 cells. XIAP mRNA and protein levels were established by RT-PCR and Immunoblot, respectively. GeneChip microarrays confirmed XIAP knockdown and absence of compensation by other IAP members.Results Four XIAP knockdown cell lines show 82-93% reduction in XIAP mRNA and 67-89% reduction in protein when compared to four luciferase control cell lines. XIAP knockdown sensitises cells to rhTRAIL by a factor of 3, to paclitaxel and docetaxel by a factor of >2 and, to a lesser extent, radiotherapy (20% enhancement).Conclusions Clinical trials with XIAP antisense continue, and these data suggest combination studies with agents such as rhTRAIL and taxanes should be undertaken.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Preclinical studies have shown that XIAP can promote resistance of CRC cells to apoptosis induced by multiple tumor treatments [251,252,253].”
From Drug Resistance in Colorectal Cancer: From Mechanism to Clinic (2022) · cites this paper as [251]
Citations
Cites
Controlling the False Discovery Rate: A Practical and Powerful Approach to Multiple Testing
Benjamini, Y., & Hochberg, Y. (1995) · Journal of the Royal Statistical Society Series B: Statistical Methodology · doi:10.1111/j.2517-6161.1995.tb02031.x · Cited by 109,482 · cited 1×
“Subsequent P values were subjected to multiple testing correction using Benjamini and Hochberg’s method for controlling the false discovery rate [ 25 ].”
MethodBioconductor: open software development for computational biology and bioinformatics
Gentleman, R. C., Carey, V. J., Bates, D. M., Bolstad, B., Dettling, M., Dudoit, S., Ellis, B., Gautier, L., Ge, Y., Gentry, J., et al. (2004) · Genome Biology · doi:10.1186/gb-2004-5-10-r80 · Cited by 12,172 · cited 1×
“Data were analysed using Bioconductor 1.8 [ 19 ] running on R 2.3.0 [20].”
MethodInfluentialSmyth, G. K. (2004) · Statistical Applications in Genetics and Molecular Biology · doi:10.2202/1544-6115.1027 · Cited by 11,829
New Colorimetric Cytotoxicity Assay for Anticancer-Drug Screening
Skehan, P., Storeng, R., Scudiero, D., Monks, A., McMahon, J., Vistica, D., Warren, J. T., Bokesch, H., Kenney, S., & Boyd, M. R. (1990) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/82.13.1107 · Cited by 9,766 · cited 2×
“Paclitaxel and docetaxel were added over a concentration range to exponentially growing cells and incubated for 72 h prior to SRB assay [ 26 ].”
Methodlimma: Linear Models for Microarray Data
Smyth, G. K. (2005) · Statistics for Biology and Health · doi:10.1007/0-387-29362-0_23 · Cited by 5,796
affy—analysis of Affymetrix GeneChip data at the probe level
Gautier, L., Cope, L., Bolstad, B. M., & Irizarry, R. A. (2004) · Bioinformatics · doi:10.1093/bioinformatics/btg405 · Cited by 5,218 · cited 1×
“Expression measures were calculated using the ‘AVy’ package’s Robust Multichip Average (RMA) default method [ 21 ].”
MethodSummaries of Affymetrix GeneChip probe level data
Irizarry, R. A. (2003) · Nucleic Acids Research · doi:10.1093/nar/gng015 · Cited by 4,887
X-linked IAP is a direct inhibitor of cell-death proteases
Deveraux, Q. L., Takahashi, R., Salvesen, G. S., & Reed, J. C. (1997) · Nature · doi:10.1038/40901 · Cited by 1,955
Suzuki, Y., Imai, Y., Nakayama, H., Takahashi, K., Takio, K., & Takahashi, R. (2001) · Molecular Cell · doi:10.1016/s1097-2765(01)00341-0 · Cited by 1,116 · cited 1×
“Other factors which have been reported as showing interactions with XIAP on literature review (MURR1 [28], akt2 [29], smac/Diablo [30], XAF1 [31], htra2/omi [ 32 ], apaf1 [12], GSPT1 [33] and NFKB [34]) were unchanged (Fig. 2a, b). The above results con-Wrm speciWc and stable 80% down regulation of XIAP with no impact…”
BackgroundMechanism of XIAP-Mediated Inhibition of Caspase-9
Shiozaki, E. N., Chai, J., Rigotti, D. J., Riedl, S. J., Li, P., Srinivasula, S. M., Alnemri, E. S., Fairman, R., & Shi, Y. (2003) · Molecular Cell · doi:10.1016/s1097-2765(03)00054-6 · Cited by 719 · cited 1×
“The main function of XIAP is inhibition of executioner caspases 3 and 7 [3] and initiator caspase 9 [ 4 ], and XIAP is the only member of the family to inhibit both phases of the cascade directly [5].”
Background
Research works printed but not linked: 1
- Ranson M, Ward T, Cummings J et al (2005) A Phase 1 Trial of AEG35156 (XIAP antisense) administered as a 7-day continuous intravenous infusion in patients with advanced tumors. Clin Cancer Res 11(24, Part 2):8965s–9216s
Cited by
Trarbach, T., Moehler, M., Heinemann, V, Köhne, C.-H., Przyborek, M., Schulz, C., Sneller, V, Gallant, G., & Kanzler, S. (2010) · British Journal of Cancer · doi:10.1038/sj.bjc.6605507 · Cited by 180
“Experimental manipulation of FLIP (Wilson et al, 2007) and XIAP (Toscano et al, 2008; Connolly et al, 2009; Wilson et al, 2009) has confirmed their critical role in mediating resistance against TRAIL-R-dependent apoptosis.”
BackgroundDrug Resistance in Colorectal Cancer: From Mechanism to Clinic
Wang, Q., Shen, X., Chen, G., & Du, J. (2022) · Cancers · doi:10.3390/cancers14122928 · Cited by 160
Inhibitors of apoptosis: clinical implications in cancer
Mohamed, M. S., Bishr, M. K., Almutairi, F. M., & Ali, A. G. (2017) · Apoptosis · doi:10.1007/s10495-017-1429-4 · Cited by 159
“Using the antisense approach, inhibition of XIAP has been reported to improve tumor control by radiotherapy and chemotherapy [216].”
BackgroundLing, X., Cao, S., Cheng, Q., Keefe, J. T., Rustum, Y. M., & Li, F. (2012) · PLoS ONE · doi:10.1371/journal.pone.0045571 · Cited by 141
Svoboda, M., Šáňa, J., Fabián, P., Kocáková, I., Gombošová, J., Nekvindová, J., Radová, L., Vyzula, R., & Slabý, O. (2012) · Radiation Oncology · doi:10.1186/1748-717x-7-195 · Cited by 136
“It was shown that knockdown of XIAP in vitro lead to sensitization of colon cancer cells to irradiation [30].”
BackgroundMellier, G., Huang, S., Shenoy, K., & Pervaiz, S. (2009) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2009.12.002 · Cited by 137
Guoan, X., Xiaomin, W., Hanning, W., Kaiyun, C., & Hao, L. (2009) · Journal of Surgical Oncology · doi:10.1002/jso.21408 · Cited by 69
“Stable XIAP knockdown clones of HCT116 colon cancer cells are more sensitive to TRAIL, taxanes and irradiation in vitro [22].”
BackgroundHuang, L., Liu, Z., Hu, J., Luo, Z., Zhang, C., Wang, L., & Wang, Z. (2020) · Pharmacological Research · doi:10.1016/j.phrs.2020.104774 · Cited by 74
Chen, L., Yuan, Y., Li, Y., Chan, T. H.-M., Zheng, B.-J., Huang, J. C., & Guan, X. (2010) · Gut · doi:10.1136/gut.2010.224071 · Cited by 52
“In recent years, adenoviral vectors carrying shRNA expression cassettes have been developed and tested in several studies.”
BackgroundMahdavi, M., Davoodi, J., Zali, M. R., & Foroumadi, A. (2011) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2011.03.001 · Cited by 51
Han, J., Liu, Z., Wang, N., & Pan, W. (2016) · Oncology Reports · doi:10.3892/or.2016.4810 · Cited by 49
RetractedAsif, M., Shafaei, A., Jafari, S. F., Mohamed, S. K., Ezzat, M. O., Majid, A. S. A., Oon, C. E., Petersen, S. H., Kono, K., & Majid, A. M. S. A. (2016) · Toxicology Letters · doi:10.1016/j.toxlet.2016.05.027 · Cited by 47
Jang, Y. L., Yun, U. J., Lee, M. S., Kim, M. G., Son, S., Lee, K., Chae, S. Y., Lim, D. W., Kim, H. T., Kim, S. H., et al. (2012) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2012.04.083 · Cited by 46
“This agrees with a previously published result, in which cancer cells having stable XIAP-knockout showed enhanced chemosensitization even in the presence of other anti-apoptotic proteins, including the members of the IAP and Bcl-2 families (Connolly et al., 2009).”
ResultDeng, S., Hu, B., An, H., Du, Q., Xu, L., Shen, K., Shi, X., Wei, M., & Wu, Y. (2013) · BMC Complementary and Alternative Medicine · doi:10.1186/1472-6882-13-128 · Cited by 45
“XIAP and Survivin may inhibit activation of Caspases, downregulation of XIAP and Survivin could sensitize colorectal cancer cell to drug induced apoptosis [41,42].”
BackgroundInhibitor of Apoptosis Proteins: Promising Targets for Cancer Therapy
Owens, T. W., Gilmore, A. P., Streuli, C. H., & Foster, F. M. (2013) · Journal of Carcinogenesis & Mutagenesis · doi:10.4172/2157-2518.s14-004 · Cited by 43
“XIAP Colorectal shRNA TRAIL Taxanes γ-irradiation [100]”
Cheong, T.-C., Shin, J., & Chun, K. (2009) · Cancer Science · doi:10.1111/j.1349-7006.2009.01364.x · Cited by 43
Zhao, J., Ling, X., Cao, S., Liu, X., Wan, S., Jiang, T., & Li, F. (2014) · Molecular Pharmaceutics · doi:10.1021/mp4004282 · Cited by 42
Zhang, W., Chen, H., LIU, D.-L., Li, H., Jiang, L., ZHANG, J.-H., Ye, L., Chen, K., Tong, H., & Lin, S. (2013) · International Journal of Oncology · doi:10.3892/ijo.2013.1839 · Cited by 40
Inhibitor of Apoptosis (IAP) proteins as therapeutic targets for radiosensitization of human cancers
Fulda, S. (2012) · Cancer Treatment Reviews · doi:10.1016/j.ctrv.2012.01.005 · Cited by 40
Zhou, S., Ye, W., Shao, Q., Qi, Y., Zhang, M., & Liang, J. (2013) · World Journal of Surgical Oncology · doi:10.1186/1477-7819-11-288 · Cited by 40
“Additionally, more and more research has shown that XIAP acts as a radioresistance factor for radiotherapy in human cancers [14-19].”
BackgroundNaturally occurring, tumor-specific, therapeutic proteins
Argiris, K., Panethymitaki, C., & Tavassoli, M. (2011) · Experimental Biology and Medicine · doi:10.1258/ebm.2011.011004 · Cited by 31
Wu, G., Mai, X., Liu, F., Lin, M., Dong, X., Xu, Q., Hao, C., Zhang, L., Yu, R., & Jiang, T. (2019) · RSC Advances · doi:10.1039/c9ra00315k · Cited by 23
Adenovirus-mediated down-regulation of X-linked inhibitor of apoptosis protein inhibits colon cancer
Dai, Y., Qiao, L., Chan, K. W., Yang, M., Ye, J., Zhang, R., Ma, J., Zou, B., Lam, C. S. C., Wang, J., et al. (2009) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-09-0509 · Cited by 25
“shRNA-based gene knockdown was reported to be a useful gene silencing approach in cancer cells with a silencing efficiency ranging from 40% to 89% knockdown (31, 32).”
BackgroundThe three Rs along the TRAIL: Resistance, re-sensitization and reactive oxygen species (ROS)
Mellier, G., & Pervaiz, S. (2012) · Free Radical Research · doi:10.3109/10715762.2012.690514 · Cited by 23
“Indeed, over-expression of Smac/DIABLO was shown to overcome X-linked IAP (XIAP) apoptotic block [63], an effect mirrored when XIAP, c-IAP-1/2 were knocked-down [64,65].”
BackgroundTargeting IAP proteins in combination with radiotherapy
Fulda, S. (2015) · Radiation Oncology · doi:10.1186/s13014-015-0399-3 · Cited by 20
“carcinoma or lung carcinoma upon genetic silencing of XIAP [15-19].”
Manzari, M. T., Anderson, G. R., Lin, K., Soderquist, R. S., Çakır, M., Zhang, M. Y., Moore, C. E., Skelton, R. N., Fevre, M., Li, X., et al. (2019) · Science Advances · doi:10.1126/sciadv.aaw9162 · Cited by 15
Exploring the Role of the Inhibitor of Apoptosis BIRC6 in Breast Cancer: A Database Analysis
Bergna, S. M. G., Marchesini, A., Morales, L. C. A., Arrías, P. N., Fariña, H. G., Romanowski, V., Gottardo, M. F., & Pidre, M. L. (2022) · JCO Clinical Cancer Informatics · doi:10.1200/cci.22.00093 · Cited by 7
Kim, H. S., Bae, S., Lim, Y. J., So, K. A., Kim, T. J., Bae, S., & Lee, J. H. (2023) · Biomedicines · doi:10.3390/biomedicines11123155 · Cited by 7
Tribbles Gene Expression Profiles in Colorectal Cancer
Fernandes, M. T., Yassuda, V., Bragança, J., Link, W., Ferreira, B. I., & Sousa‐Coelho, A. L. D. (2021) · Gastrointestinal Disorders · doi:10.3390/gidisord3040021 · Cited by 2
“From these, six were from genetically modified cell lines (Table S3), which included SW480 cells stably overexpressing Snail (GDS4596), [60], HCT116 cells depleted of PTEN by gene targeting (GDS2446) [61], HCT116 cells, either fully (p53+/+), partially (p53−/+), or not (p53−/−) expressing TP53 tumor suppressor (GDS170…”
BackgroundWaniczek, D., Nowak, M., Lorenc-Góra, J., Muc‐Wierzgoń, M., Mazurek, U. M., Bichalska-Lach, M., & Lorenc, Z. (2021) · Medicine · doi:10.1097/md.0000000000027882 · Cited by 2
“The inhibition of apoptosis is crucial in CC carcinogenesis, hence the following thought-provoking question – could IAPs be potential markers for CC?.([8,10,20,24,25,26,27,28]) In the colon, BIRC5 was detected in small amounts in mucosa obtained from healthy tissue margins.”
Novel Role of CHK2 in the Intrinsic and Extrinsic Apoptosis Pathway
Agarwal, A. (2014) · Open Scholarship Institutional Repository (Washington University in St. Louis) · doi:10.7936/k7ng4nnv
“Knockdown of XIAP increases the sensitivity of chemotherapy in colorectal (Connolly et al., 2009), breast (Lima et al.”
Induktion der Apoptose in TRAIL-resistenten Krebszellen
Kochanek, S. (2010)
Συμμετοχή του αποπτωτικού μονοπατιού TRAIL στην καρκινογένεση
Τσικαλάκης, Σ. (2018) · doi:10.12681/eadd/43330
Bergna, S. M. G. (2020) · El Servicio de Difusión de la Creación Intelectual (National University of La Plata)
Metadata
- Authors
- Connolly, K., Mitter, R., Muir, M., Jodrell, D., & Guichard, S.
- Affiliations
- Edinburgh Cancer Research (GB)
- Cancer Research UK (GB)
- University of Cambridge (GB)
- AstraZeneca (United Kingdom) (GB)
- Corresponding author
- Connolly, Kate
- Venue
- Cancer Chemotherapy and Pharmacology
- Published
- 2008-11-26
- Volume
- 64
- Issue
- 2
- Pages
- 307-316
- ISSN
- 0344-5704 (ISSN-L)
- 1432-0843
- OpenAlex
- W2001633094
- Cited by
- 34
- References
- 49
- Citations by year
- 2023: 1 · 2022: 2 · 2021: 3 · 2020: 1 · 2019: 2 · 2017: 1 · 2016: 2 · 2015: 1 · 2014: 1 · 2013: 5 · 2012: 5
- FWCI
- 1.37
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Cancer Chemotherapy and Pharmacology (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Cancer Research UK (C96/A4743)
- University of Manchester
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Cell death mechanisms and regulation
- Health Sciences › Medicine › Oncology › Cancer-related Molecular Pathways
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › NF-κB Signaling Pathways
- Keywords
- XIAP, X-linked inhibitor of apoptosis, HCT116 cells, colorectal cancer, shRNA, gene knockdown, TRAIL, paclitaxel, docetaxel, radiosensitization, apoptosis inhibitor, combination therapy
- MeSH terms
- Animals, Colonic Neoplasms, Flow Cytometry, Gamma Rays, Humans, Mice, Nude, RNA, Messenger, Tumor Cells, Cultured, Immunoblotting, Reverse Transcriptase Polymerase Chain Reaction, Caspases, Oligonucleotide Array Sequence Analysis, Gene Expression Profiling, Xenograft Model Antitumor Assays, RNA, Small Interfering, Taxoids, Cell Proliferation, Mice, X-Linked Inhibitor of Apoptosis Protein, TNF-Related Apoptosis-Inducing Ligand, Gene Knockdown Techniques, In Vitro Techniques
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.